[ad_1] It may be time to get your COVID-19 vaccine again. There’s a new booster that’s coming out to guard against the virus. The Centers for...
[ad_1] The Centers for Disease Control and Prevention on Tuesday recommended updated COVID-19 vaccines for people 6 months of age and older. Director Mandy Cohen late...
[ad_1] The World Health Organization has called on China to release more information about its current wave of COVID infections after China said nearly 60,000 people...
[ad_1] The XBB.1.5 omicron subvariant that has been dominant in the Northeast for several weeks is now officially dominant across the U.S., according to an update...
[ad_1] China on Tuesday suspended visas for South Koreans to enter the country for tourism or business in apparent retaliation for South Korea’s COVID-19 testing requirements...
[ad_1] COVID-19 cases are once again rising in the U.S., but how prepared are we for the next pandemic? That’s a question worth asking. The $1.7...
[ad_1] Omicron subvariants continued to account for more new cases of COVID-19 in the U.S. in the latest week than did BA.5, according to the latest...
[ad_1] The head of the International Monetary Fund on Tuesday joined the chorus of people urging China to adopt a more targeted approach to the coronavirus...
[ad_1] Widespread protests across China over the government’s zero-COVID policy dominated pandemic headlines Monday, with Anthony Fauci, President Joe Biden’s chief medical adviser, weighing in with...
[ad_1] As we head into the third winter of the pandemic, only about 13% of American adults — less than 11% of Americans overall — have...
[ad_1] A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster showed strong results against the newer omicron sublineages, Pfizer and...
[ad_1] The head of the World Health Organization said a close to 90% decline in COVID deaths globally compared to nine months ago is “cause for...
[ad_1] China’s strict zero-COVID policy was making headlines Monday after Apple and iPhone manufacturer Foxconn said over the weekend that restrictions are crimping production and will...
[ad_1] First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data for their omicron BA.4/BA.5-adapted bivalent booster showed a “substantially higher”...
[ad_1] The Centers for Disease Control and Prevention has refuted claims that it’s planning to add the COVID-19 vaccine to immunization schedules for schoolchildren, saying that...
[ad_1] Pfizer Inc. PFE, +4.17% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +7.14% for $110 to $130...
[ad_1] The Centers for Disease Control and Prevention said a new COVID variant dubbed BQ.1 and a descendant called BQ.1.1 have gained traction in the U.S.,...
[ad_1] Pfizer Inc. PFE, +0.26% and German partner BioNTech SE BNTX, +5.53% said Thursday early data from a Phase 2/3 clinical trial of their omicron BA.4/BA.5-adapated...
[ad_1] About half of the American public has heard little or nothing about the new COVID-19 bivalent booster, a new survey by the Kaiser Family Foundation...